Zentalis grants stock options for 62,000 shares to three new hires under inducement plan

Bitget2026/10/01 21:10

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Zentalis Pharmaceuticals granted non-qualified stock options covering 62,000 shares to three newly hired employees on Oct. 1, 2026.
Awards were issued under the company’s 2022 Employment Inducement Incentive Award Plan.
Options carry an exercise price of USD 2.605 per share, matching the Nasdaq closing price on the grant date.
Term runs 10 years; vesting spans four years with 25% after one year, then monthly installments over three years.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zentalis Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610011710PRIMZONEFULLFEED9838285) on October 01, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Zentalis grants stock options for 62,000 shares to three new hires under inducement plan

You may also like

Crypto prices